Effects of stenting on exercise capacity in patients with certain congenital heart defects
Official title: The Effects of Branch Pulmonary Artery Stenting in d-TGA, ToF and TA: a Randomized Control Trial
Run by UMC Utrecht · NCT05809310 · Data updated 2026-11-12
This study is testing if a procedure to open blocked arteries can help people with certain heart defects, like d-TGA, ToF, and TA, exercise better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years and up |
| Sex | All |
| Enrollment | 56 (estimated) |
| Sponsor | UMC Utrecht Academic / other |
| Locations | 4 sites (Amsterdam and 3 other locations) |
| Status | Recruiting |
| Started | April 18, 2023 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | March 30, 2025 |
| Trial ID | NCT05809310 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients aged 8 years and older with d-TGA post arterial switch operation, ToF, or TA.
✕Probably not a fit
Patients with significant comorbidities or severe right ventricular dysfunction may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the impact of percutaneous interventions for branch pulmonary artery stenosis on exercise capacity in patients with dextro transposition of the great arteries (d-TGA), Tetralogy of Fallot (ToF), and Truncus Arteriosus (TA). Participants will undergo a series of examinations, including echocardiograms and cardiopulmonary exercise testing, at baseline and approximately six months later. The study also seeks to assess right ventricular function and identify early markers for improving the timing of these interventions. It is a multicenter randomized controlled trial conducted across several Dutch interventional centers.
Why it matters
Potential benefit: If successful, this study could enhance exercise capacity and overall quality of life for patients with specific congenital heart defects.
How similar studies have gone: While the effects of percutaneous interventions for branch PA stenosis are not well-established, similar approaches in other studies have shown promise in improving outcomes for patients with congenital heart defects.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Patients with d-TGA post ASO, ToF or TA * ≥8 years Exclusion Criteria: One or more of the following inclusion criteria: * All class IIa indications for a branch PA intervention: * Persistent decreased RV function (based on gold standard CMR) * \<18 years RVEF ≤55% (28) * ≥18 years RVEF\<50% (29) * Progressive tricuspid regurgitation (TR) (≥moderate) * Isolated bifurcation stenosis: * Significant unilateral stenosis (≥50%) * Borderline bilateral PA stenosis (40-70%) * Unbalanced perfusion (≤35/65%) * RV/LV pressure ratio \> 2/3 based on echocardiography * Reduced lung perfusion or decreased objective exercise capacity (based of gold standard VO2 max during CPET) * \<18 years VO2 peak \<35 mL∙kg-1∙min-1 (boys) VO2 peak \<30 mL∙kg-1∙min-1 (girls) (30) * ≥18 years VO2 peak \<27 mL∙kg-1∙min-1 (men) VO2 peak \<19 mL∙kg-1∙min-1 (women) (31)
Where it's running
-
UMC Utrecht/WKZ
Utrecht, Netherlands Recruiting -
Amsterdam University Medical Center location AMC
Amsterdam, Netherlands Not yet recruiting -
Leiden University Medical Center
Leiden, Netherlands Not yet recruiting -
Erasmus Medical Center
Rotterdam, Netherlands Not yet recruiting
Study contacts
- Study coordinator: Hans Breur, MD, PhD
- Email: h.breur@umcutrecht.nl
- Phone: +31 88 75 754 59
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High intensity interval training for patients with congenital heart defects
This study is testing if a 12-week home workout program can help young people with certain heart defects exercise better and feel stronger.
-
Integrated prenatal and postnatal treatment for newborns with critical congenital heart disease
This study is testing a new approach that combines care before and after birth for newborns with serious heart defects to see if it can improve their treatment and recovery.
-
Evaluation of the MASA Valve for heart surgery in children
This study is testing a new heart valve designed for children with certain heart defects to see if it is safe and helps improve their heart function.
-
Understanding heart issues in patients with congenital heart disease
This study is trying to understand what causes symptoms like shortness of breath and palpitations in people with congenital heart disease, especially those with Tetralogy of Fallot, by using remote heart monitoring.
-
Monitoring oxygen levels in newborns with congenital heart defects
This study is testing a new way to monitor oxygen levels in newborns with congenital heart defects to see how it can help doctors understand their heart and blood flow better.
-
Registry of patients with Tetralogy of Fallot using implantable defibrillators
This study is creating a national registry to track adult patients in France with Tetralogy of Fallot who have implantable defibrillators, to better understand their health over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.